Results 71 to 80 of about 26,023 (245)
Stability of apomorphine in solutions containing selected antioxidant agents
Drug Design, Development and Therapy, 2016 Zen Yang Ang, Michael Boddy, Yandi Liu, Bruce Sunderland School of Pharmacy, Faculty of Health Sciences, Curtin University, Bentley, WA, Australia Abstract: Apomorphine in solution undergoes rapid autoxidation, producing greenish colored solutions ...
Ang ZY, Boddy M, Liu Y, Sunderland B
doaj
Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta‐Analysis
European Journal of Neurology, Volume 33, Issue 2, February 2026.ABSTRACT Background Many Parkinson's disease patients receiving oral levodopa/carbidopa experience a troublesome wearing off effect. Higher doses to mitigate OFF‐time are limited by adverse effects occurring at peak dopamine levels, particularly dyskinesia.
Matthew Burton +6 more
wiley +1 more source
The Pharmacological Properties and Therapeutic Use of Apomorphine
Molecules, 2012 Apomorphine <strong>(</strong>APO) is an aporphine derivative used in human and veterinary medicine. APO activates D<sub>1</sub>, D<sub>2S</sub>, D<sub>2L</sub>, D<sub>3</sub>, D<sub>4</
Samo Ribarič
doaj +1 more source
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal behavior in a Rat Model of Parkinson’s Disease [PDF]
, 2017 Research in the last decade strongly suggests that mesenchymal stem cell (MSC)-mediated therapeutic benefits are mainly due to their secretome, which has been proposed as a possible therapeutic tool for the treatment of Parkinson's disease (PD).
Allen +74 more
core +1 more source
Advanced Healthcare Materials, Volume 15, Issue 4, 26 January 2026.Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao +2 more
wiley +1 more source
Effects of dance therapy on balance, gait and neuro-psychological performances in patients with Parkinson's disease and postural instability [PDF]
, 2012 Postural Instability (PI) is a core feature of Parkinson’s Disease (PD) and a major cause of falls and disabilities. Impairment of executive functions has been called as an aggravating factor on motor performances. Dance therapy has been shown effective
Agnetti, Virgilio +6 more
core
Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 98-107, January 2026.Abstract Background Dyskinesia is a debilitating complication of dopaminergic therapy in advanced Parkinson's disease. Objectives To evaluate the effect of levodopa‐carbidopa intestinal gel (LCIG) on dyskinesia burden. Methods This is a post hoc analysis of the retrospective, observational COmedication Study assessing Mono‐ and cOmbination therapy with
Alfonso Fasano +11 more
wiley +1 more source
Refractory Motor Complications: Towards a Pragmatic Definition
Movement Disorders Clinical Practice, EarlyView.
Georg Ebersbach, Tobias Warnecke
wiley +1 more source
Endogenous Dopamine and Endocannabinoid Signaling Mediate Cocaine-Induced Reversal of AMPAR Synaptic Potentiation in the Nucleus Accumbens Shell [PDF]
, 2018 Repeated exposure to drugs of abuse alters the structure and function of neural circuits mediating reward, generating maladaptive plasticity in circuits critical for motivated behavior.
Hearing, Matthew +3 more
core +2 more sources